Skip to main content
. 2024 Jun 18;15:1379056. doi: 10.3389/fimmu.2024.1379056

Table 3.

One-year progression free survival probability by organ site of disease.

Organ site One-year PFS (%) Pairwise log-rank test comparison to BoMs, p-value
Abdominal 16.2% (8.6–25.8) 0.40
Adrenal 26.2% (19.0–33.9) 0.03*
Bone 17.8% (13.6–22.4)
Brain 26.3% (19.2–33.9) 0.03*
Liver 15.7% (10.7–21.5) 0.20
Lung 30.2% (26.4–34.1) <0.005*
Lymph 34.3% (30.0–38.7) <0.005*

*Indicates statistical significance, p<0.05.

PFS, progression free survival; BoMs, bone metastases.